Psychosocial factors are associated with prolonged hospitalization in a population with advanced HIV

被引:9
作者
Cheng, AC
Mijch, AM
Hoy, JF
Wesselingh, SL
Fairley, CK
机构
[1] Divison of Infectious Diseases, Box 3824, Duke University Medical Center, Durham
[2] Infectious Diseases Unit, Alfred Hospital, Prahan, Vic 3182, Commercial Road
关键词
HIV infections; acquired immunodeficiency syndrome; mental disorders; social environment; hospitalization; substance-related disorders; morbidity; mortality;
D O I
10.1258/0956462011923129
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Our aim was to define a subgroup of patients with HIV at risk of adverse outcomes in terms of psychosocial factors in order to improve the targeting of hospital resources. The International Classification of Diseases, 9th Revision (ICD-9) coded discharges of all inpatients with HIV discharged from a tertiary hospital between July 1996 and March 1999 were matched against variables in the HIV/AIDS database. A 'prolonged hospitalization' subgroup was defined as those patients whose cumulative length of stay exceeded 90 days in the 33-month period. There were 2778 non-day stay discharges (n=757 patients) constituting 21,286 bed-days. The prolonged hospitalization group (n=62) accounted for 44.3% of the bed-days. Psychosocial co-diagnoses were associated with prolonged hospitalization in both crude and adjusted logistic analyses. These included psychiatric diagnoses such as mania, psychosis and anxiety, HIV dementia, housing issues and the need for social work interventions. In conclusion, a small group of individuals at risk of adverse outcomes has been defined by markers of psychosocial dysfunction. Increased understanding of this group should enable the development of programmes directed at morbidity and mortality.
引用
收藏
页码:302 / 306
页数:5
相关论文
共 16 条
[1]  
Aboulker JP, 1999, AIDS, V13, P565, DOI 10.1097/00002030-199904010-00005
[2]   HIV disease progression in Australia in the time of combination antiretroviral therapies [J].
Correll, PK ;
Law, MG ;
McDonald, AM ;
Cooper, DA ;
Kaldor, JM .
MEDICAL JOURNAL OF AUSTRALIA, 1998, 169 (09) :469-472
[3]  
DHINGRA R, 2000, 13 INT AIDS C DURB S
[4]   Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study [J].
Egger, M ;
Hirschel, B ;
Francioli, P ;
Sudre, P ;
Wirz, M ;
Flepp, M ;
Rickenbach, M ;
Malinverni, R ;
Vernazza, P ;
Battegay, M ;
Bernasconi, E ;
Burgisser, P ;
Erb, P ;
Fierz, W ;
Grob, P ;
Gruninger, U ;
Jeannerod, L ;
Ledergerber, B ;
Luthy, R ;
Matter, L ;
Opravil, M ;
Paccaud, F ;
Perrin, L ;
Pichler, W ;
Piffaretti, GC ;
Rutschmann, O ;
Zanetti, G .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7117) :1194-1199
[5]   Monitoring plasma HIV-1 RNA levels in addition to CD4(+) lymphocyte count improves assessment of antiretroviral therapeutic response [J].
Hughes, MD ;
Johnson, VA ;
Hirsch, MS ;
Bremer, JW ;
Elbeik, T ;
Erice, A ;
Kuritzkes, DR ;
Scott, WA ;
Spector, SA ;
Basgoz, N ;
Fischl, MA ;
DAquila, RT .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (12) :929-938
[6]   Protease inhibitor-based therapy is associated with decreased HIV-related health care costs in men treated at a Veterans Administration Hospital [J].
Keiser, P ;
Kvanli, MB ;
Turner, D ;
Reisch, J ;
Smith, JW ;
Nassar, N ;
Gregg, C ;
Skiest, D .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1999, 20 (01) :28-33
[7]   Plasma viral load and CD4(+) lymphocytes as prognostic markers of HIV-1 infection [J].
Mellors, JW ;
Munoz, A ;
Giorgi, JV ;
Margolick, JB ;
Tassoni, CJ ;
Gupta, P ;
Kingsley, LA ;
Todd, JA ;
Saah, AJ ;
Detels, R ;
Phair, JP ;
Rinaldo, CR .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (12) :946-954
[8]  
MOUTON Y, 1997, AIDS, V11, P101
[9]  
*NAT CTR HIV EP CL, 1999, HIV AIDS HEP C SEX T
[10]  
*NTA COD CTR, 1996, AUSTR VERS INT CLASS